Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

What challenges do clinicians face in monitoring in disease progrission and response to therapy?

Have you observed any significant differences in treatment outcomes between these two therapies in your local practice?

How has avalglucosidase alfa impacted the treatment paradigm for both infantile-onset and late-onset Pompe disease in your experience?

Pompe Care Podcast Series 3

What factors influence your decision to switch a patient from alglucosidase alfa to avalglucosidase alfa?

Structured Monitoring for Early Detection of Fabry Progression

Renal Outcomes After Switching to Agalsidase Beta: A Single-Center Analysis

Dupilumab for Patients with AFRS

The Many Faces of Limb-Girdle Weakness

Differentail Diagnosis for Unspecific Limb - Girdle Muscular Dystrophy (LGMD)/ Dr. Alanood Alsolaihim

When the Heart, Kidneys, and Nerves Intersect

Differentail Diagnosis for Patient with Unexplained Neuropathic Pain, Unknown LVH, or Dialysis Requirements. Dr. Khalid Naji

When Weakness Tells a Bigger Story

It's Not Just A Wakness/ Dr. Ahmed Bamaga

The Enlarged Spleen Mystery

Patient With Hepatosplenomegaly and Multiple Splenic lesions/Dr. Ahmed Al Shomer